Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The overtraining syndrome in athletes: A stress-related disorder


Physical exercise is a type of allostatic load for several endocrine systems, notably the hypothalamic-pituitary-adrenal (HPA) axis. Athletes undergoing a strenuous training schedule can develop a significant decrease in performance associated with systemic symptoms or signs: the overtraining syndrome (OTS). This is a stress-related condition that consists of alteration of physiological functions and adaptation to performance, impairment of psychological processing, immunological dysfunction and biochemical abnormalities. Universally agreed diagnostic criteria for OTS are lacking. The pituitary-adrenal response to a standardized exercise test is usually reduced in overtrained athletes. This HPA dysfunction could reflect the exhaustion stage of Selye’s general adaptation syndrome. The most attractive hypothesis that accounts for the observed neuro-endocrine-immune dysregulation is the Smith’s cytokine hypothesis of OTS. It assumes that physical training can produce muscle and skeletal trauma, thus generating a local inflammatory reaction. With the excessive repetition of the training stimulus the local inflammation can generate a systemic inflammatory response. The main actors of these processes are the cytokines, polypeptides that modulate HPA function in and outside the brain at nearly every level of activity. It is hoped that future research will focus on endogenous risk factors for morbidities related to the neuro-endocrine-immune adaptation to exercise.

This is a preview of subscription content, log in to check access.


  1. 1.

    Selye H. Syndrome produced by diverse nocuous agents. Nature 1936, 138: 32.

  2. 2.

    Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Fisher S, Reason J eds. Handbook of life stress, cognition and health. New York: John Wiley. 1988, 629–49.

  3. 3.

    McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med 1993, 153: 2093–101.

  4. 4.

    McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998, 338: 171–9.

  5. 5.

    Farrell PA, Garthwaite TL, Gustafson AB. Plasma adrenocorticotropin and cortisol responses to submaximal and exhaustive exercise. J Appl Physiol 1983, 55: 1441–4.

  6. 6.

    Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997, 20: 78–84.

  7. 7.

    Luger A, Deuster PA, Kyle SB, et al. Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med 1987, 316: 1309–15.

  8. 8.

    Duclos M, Corcuff JB, Pehourcq F, Tabarin A. Decreased pituitary sensitivity to glucocorticoids in endurance-trained men. Eur J Endocrinol 2001, 144: 363–8.

  9. 9.

    Duclos M, Corcuff JB, Rashedi M, Fougere V, Manier G. Trained versus untrained men: different immediate post-exercise responses of pituitary adrenal axis. A preliminary study. Eur J Appl Physiol Occup Physiol 1997, 75: 343–50.

  10. 10.

    Wittert GA, Livesey JH, Espiner EA, Donald RA. Adaptation of the hypothalamopituitary adrenal axis to chronic exercise stress in humans. Med Sci Sports Exerc 1996, 28: 1015–9.

  11. 11.

    Haas DA, George SR. Single or repeated mild stress increases synthesis and release of hypothalamic corticotropin-releasing factor. Brain Res 1988, 461: 230–7.

  12. 12.

    Bremner JD, Licinio J, Darnell A, et al. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 1997, 154: 624–9.

  13. 13.

    Giordano R, Rossetto R, Baffoni C, et al. Adrenal sensitivity to ACTH1-24 as function of age, body weight and pituitary function. J Endocrinol Invest 2002, 25 (10 Suppl): 85–6.

  14. 14.

    Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25: 1–35.

  15. 15.

    Fellmann N, Bedu M, Boudet G, et al. Inter-relationships between pituitary-adrenal hormones and catecholamines during a 6-day Nordic ski race. Eur J Appl Physiol Occup Physiol 1992, 64: 258–65.

  16. 16.

    Viru AM, Hackney AC, Valja E, Karelson K, Janson T, Viru M. Influence of prolonged continuous exercise on hormone responses to subsequent exercise in humans. Eur J Appl Physiol 2001, 85: 578–85.

  17. 17.

    Kanaley JA, Hartman ML. Cortisol and growth hormone responses to exercise. The Endocrinologist 2002, 12: 421–32.

  18. 18.

    Del Corral P, Sampedro R, Hartsell M, et al. Reduced cortisol potentiates the exercise-induced increase in corticotropin to a greater extent in trained compared with untrained men. Metabolism 1999, 48: 390–4.

  19. 19.

    Armstrong LE, Van Heest JL. The unknown mechanism of the overtraining syndrome: clues from depression and psychoneuroimmunology. Sports Med 2002, 32: 185–209.

  20. 20.

    Fry RW, Morton AR, Keast D. Overtraining in athletes. An update. Sports Med 1991, 12: 32–65.

  21. 21.

    Koutedakis Y, Sharp NC. Seasonal variations of injury and overtraining in elite athletes. Clin J Sport Med 1998, 8: 18–21.

  22. 22.

    Kentta G, Hassmen P, Raglin JS. Training practices and overtraining syndrome in Swedish age-group athletes. Int J Sports Med 2001, 22: 460–5.

  23. 23.

    Budgett R. Fatigue and underperformance in athletes: the overtraining syndrome. Br J Sports Med 1998, 32: 107–10.

  24. 24.

    Israel S. Die Erscheinungsformen des Übertrainings. Sportmed. 1958, 9: 207–9.

  25. 25.

    Lehmann M, Foster C, Keul J. Overtraining in endurance athletes: a brief review. Med Sci Sports Exerc 1993, 25: 854–62.

  26. 26.

    Mackinnon LT, Rubinstein I. Chronic exercise training effects on immune function. Med Sci Sports Exerc 2000, 32: S369–76.

  27. 27.

    Nieman DC. Special feature for the Olympics: effects of exercise on the immune system: exercise effects on systemic immunity. Immunol Cell Biol 2000, 78: 496–501.

  28. 28.

    MacKinnon LT. Special feature for the Olympics: effects of exercise on the immune system: overtraining effects on immunity and performance in athletes. Immunol Cell Biol 2000, 78: 502–9.

  29. 29.

    Gleeson M, Pyne DB. Special feature for the Olympics: effects of exercise on the immune system: exercise effects on mucosal immunity. Immunol Cell Biol 2000, 78: 536–44.

  30. 30.

    Urhausen A, Kindermann W. Diagnosis of overtraining: what tools do we have? Sports Med 2002, 32: 95–102.

  31. 31.

    Urhausen A, Gabriel HH, Weiler B, Kindermann W. Ergometric and psychological findings during overtraining: a long-term follow-up study in endurance athletes. Int J Sports Med 1998, 19: 114–20.

  32. 32.

    Hedelin R, Wiklund U, Bjerle P, Henriksson-Larsen K. Cardiac autonomic imbalance in an overtrained athlete. Med Sci Sports Exerc 2000, 32: 1531–3.

  33. 33.

    Sacknoff DM, Gleim GW, Stachenfeld N, Coplan NL. Effect of athletic training on heart rate variability. Am Heart J 1994, 127: 1275–8.

  34. 34.

    Vervoorn C, Quist AM, Vermulst LJ, Erich WB, de Vries WR, Thijssen JH. The behaviour of the plasma free testosterone/cortisol ratio during a season of elite rowing training. Int J Sports Med 1991, 12: 257–63.

  35. 35.

    Urhausen A, Gabriel H, Kindermann W. Blood hormones as markers of training stress and overtraining. Sports Med 1995, 20: 251–76.

  36. 36.

    Lehmann M, Schnee W, Scheu R, Stockhausen W, Bachl N. Decreased nocturnal catecholamine excretion: parameter for an overtraining syndrome in athletes? Int J Sports Med 1992, 13: 236–42.

  37. 37.

    Minetto M, Paccotti P, Ventura M, et al. Overtraining syndrome: an integrated approach to diagnosis using a maximal exercise test and surface electromyography. Program of the International Congress “Hormones, Body Composition and Physical Performances”, Turin, Italy, 2002, p. 106 (abstract).

  38. 38.

    Cleare AJ. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 2003, 24: 236–52.

  39. 39.

    Deuster PA, Petrides JS, Singh A, Chrousos GP, Poth M. Endocrine response to high-intensity exercise: dose-dependent effects of dexamethasone. J Clin Endocrinol Metab 2000, 85: 1066–73.

  40. 40.

    Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991, 73: 1224–34.

  41. 41.

    Ottenweller JE, Sisto SA, McCarty RC, Natelson BH. Hormonal responses to exercise in chronic fatigue syndrome. Neuropsychobiology 2001, 43: 34–41.

  42. 42.

    Gaab J, Huster D, Peisen R, et al. Hypothalamic-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological, and pharmacological stimulation. Psychosom Med 2002, 64: 951–62.

  43. 43.

    Hudson JI, Pope HG. The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol 1994, 8: 839–56.

  44. 44.

    Yunus MB. Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Baillieres Clin Rheumatol 1994, 8: 811–37.

  45. 45.

    Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997, 4: 134–53.

  46. 46.

    Yehuda R. Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder. Ann NY Acad Sci 1997, 821: 57–75.

  47. 47.

    Yehuda R. Psychoneuroendocrinology of post-traumatic stress disorder. Psychiatr Clin North Am 1998, 21: 359–79.

  48. 48.

    Yehuda R. Post-traumatic stress disorder. N Engl J Med 2002, 346: 108–14.

  49. 49.

    De Bellis MD, Chrousos GP, Dorn LD, et al. Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J Clin Endocrinol Metab 1994, 78: 249–55.

  50. 50.

    Yehuda R, Levengood RA, Schmeidler J, Wilson S, Guo LS, Gerber D. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology 1996, 21: 1–16.

  51. 51.

    Ala Y, Palluy O, Favero J, Bonne C, Modat G, Dornand J. Hypoxia/reoxygenation stimulates endothelial cells to promote interleukin-1 and interleukin-6 production. Effects of free radical scavengers. Agents Actions 1992, 37: 134–9.

  52. 52.

    Smith LL. Cytokine hypothesis of overtraining: a physiological adaptation to excessive stress? Med Sci Sports Exerc 2000, 32: 317–31.

  53. 53.

    Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 1999, 79: 1–71.

  54. 54.

    Neveu PJ. Brain-immune cross-talk. Stress 2003, 6: 3–4.

  55. 55.

    Buller KM. Neuroimmune stress responses: reciprocal connections between the hypothalamus and the brainstem. Stress 2003, 6: 11–7.

  56. 56.

    Tomlinson JW, Moore J, Cooper MS, et al. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 2001, 142: 1982–9.

  57. 57.

    Cooper MS, Bujalska I, Rabbitt E, Et al. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res 2001, 16: 1037–44.

  58. 58.

    Angeli A, Dovio A, Sartori ML, et al. Interactions between glucocorticoids and cytokines in the bone microenvironment. Ann NY Acad Sci 2002, 966: 97–107.

  59. 59.

    Dovio A, Sartori ML, Masera RG, et al. Autocrine down-regulation of glucocorticoid receptors by interleukin-11 in human osteoblast-like cell lines. J Endocrinol 2003, 177: 109–17.

  60. 60.

    Hayley S, Merali Z, Anisman H. Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness. Stress 2003, 6: 19–32.

  61. 61.

    Papanicolaou DA, Petrides JS, Tsigos C, et al. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 1996, 271: E601–5.

  62. 62.

    Angeli A, Minetto M, Ventura M, Dovio A, Paccotti P. Exercise and the hypothalamic-pituitary-adrenal axis. Program of the International Congress “Hormones, Body composition and Physical performances”, Turin, Italy, 2002, p. 36 (abstract).

  63. 63.

    Ceci SJ. Can one forget to remember? Science 2003, 301: 465.

  64. 64.

    Fry AC, Kraemer WJ, Ramsey LT. Pituitary-adrenal-gonadal responses to high-intensity resistance exercise overtraining. J Appl Physiol 1998, 85: 2352–9.

  65. 65.

    Connor KM, Davidson JR. Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. Biol Psychiatry 1998, 15: 1286–94.

  66. 66.

    Brebner K, Hayley S, Zacharko R, Merali Z, Anisman H. Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology 2000, 22: 566–80.

  67. 67.

    Hayley S, Merali Z, Anisman H. Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness. Stress 2003, 6: 19–32.

  68. 68.

    Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993, 47: 169–76.

  69. 69.

    Plotkin SR, Banks WA, Kastin AJ. Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier. J Neuroimmunol 1996, 67: 41–7.

  70. 70.

    Banks WA. Cytokines, CVSs, and the blood-brain barrier. In: Ader R, Felten DI, Cohen N eds. Psychoneuroimmunology, Vol. 2. New York: academic Press. 2001, 483–98.

  71. 71.

    Ericsson A, Arias C, Sawchenko PE. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J Neurosci 1997, 17: 7166–79.

  72. 72.

    Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2001, 26: 761–88.

  73. 73.

    Mark KS, Trickler WJ, Miller DW. Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. J Pharmacol Exp Ther 2001, 297: 1051–8.

  74. 74.

    Dantzer R, Bluthe RM, Aubert A, et al. Cytokine actions on behavior. In: Rothwell NJ eds. Cytokines and the Nervous System. London: Landes. 1996, 117–44.

  75. 75.

    Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998, 105: 83–107.

  76. 76.

    Mayhan WG. Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier. Brain Res 2002, 927: 144–52.

  77. 77.

    Buller KM. Neuroimmune stress responses: reciprocal connections between the hypothalamus and the brainstem. Stress 2003, 6: 11–7.

  78. 78.

    Di Luigi L, Guidetti L, Romanelli F, Baldari C, Conte D. Acetylsalicylic acid inhibits the pituitary response to exercise-related stress in humans. Med Sci Sports Exerc 2001, 33: 2029–35.

  79. 79.

    Irwin J, Ahluwalia P, Zacharko RM, Anisman H. Central norepinephrine and plasma corticosterone following acute and chronic stressors: influence of social isolation and handling. Pharmacol Biochem Behav 1986, 24: 1151–4.

  80. 80.

    de Kloet RE. Hormones, brain and stress. Endocr Regul 2003, 37: 51–68.

  81. 81.

    Bhatnagar S, Dallman M. Neuroanatomical basis for facilitation of hypothalamic-pituitary-adrenal responses to a novel stressor after chronic stress. Neuroscience 1998, 84: 1025–39.

  82. 82.

    Nelson PT, Soma LA, Lavi E. Microglia in diseases of the central nervous system. Ann Med 2002, 34: 491–500.

  83. 83.

    Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP. The role of glial reaction and inflammation in Parkinson’s disease. Ann NY Acad Sci 2003, 991: 214–28.

  84. 84.

    Blasko I, Grubeck-Loebenstein B. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer’s disease. Drugs Aging 2003, 20: 101–13.

  85. 85.

    Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002, 53: 865–71.

  86. 86.

    Habib KE, Gold PW, Chrousos GP. Neuroendocrinology of stress. Endocrinol Metab Clin North Am 2001, 30: 695–728.

  87. 87.

    Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999, 340: 115–26.

  88. 88.

    Libby P. Inflammation in atherosclerosis. Nature 2002, 420: 868–74.

  89. 89.

    Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E, Connell JM. Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 1999, 33: 1364–8.

  90. 90.

    Rosmond R. The glucocorticoid receptor gene and its association to metabolic syndrome. Obes Res 2002, 10: 1078–86.

  91. 91.

    Terzolo M, Pia A, Ali A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002, 87: 998–1003.

  92. 92.

    Pihl E, Jurimae T. Relationships between body weight change and cardiovascular disease risk factors in male former athletes. Int J Obes Relat Metab Disord 2001, 25: 1057–62.

Download references

Author information

Correspondence to M. Minetto MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Angeli, A., Minetto, M., Dovio, A. et al. The overtraining syndrome in athletes: A stress-related disorder. J Endocrinol Invest 27, 603–612 (2004). https://doi.org/10.1007/BF03347487

Download citation


  • Overtraining syndrome
  • HPA axis
  • cytokines
  • brain-immune interactions